Best way to treat malaria: Avoid using same drug for everyone, scientists say

September 08, 2008

A team of scientists employing a sophisticated computer model pioneered at Princeton University and Resources for the Future has found that many governments worldwide are recommending the wrong kind of malaria treatment.

Despite the availability of many drugs and therapies to treat malaria, many countries' national policies recommend using what is known as a single first-line therapy -- that is, using one drug repeatedly with many patients. Writing in the Sept. 16 issue of the Proceedings of the National Academy of Sciences, a team led by Maciej Boni, who conducted the research as a postdoctoral fellow at Princeton and scholar at Resources, a Washington, D.C.-based think tank, reports that countries could cut the death rate and forestall the development of drug resistance if a variety of different drugs were distributed to patients.

This approach, known as multiple first-line therapies or MFT, could be put into place by making sure different drugs cost about the same, so that patients would not be forced into buying the cheapest available drug but would choose from a random pool. Or it could be applied by clinic physicians who could simply alternate their choices for drugs they prescribe to patients.

"What we found is that using multiple first-line therapies is the best way to avoid treatment failures and to delay the development of resistance for as long as possible," said Boni, who recently has joined the staff of the Oxford University Clinical Research Unit in Ho Chi Minh City, Vietnam.

One catch to the researchers' strategy is that multiple effective therapies may not always be available. In some African countries where drug-resistance is already widespread, the only effective therapies are a class of drugs known as artemisinin-based combination therapies (ACTs).

"MFT does not necessarily solve all our problems," said Boni. "Antimalarial drug development needs to continue with the hope of producing novel and highly effective antimalarials that can be deployed alongside ACTs."

Some 350 to 500 million people are infected with malaria every year by being bitten by a mosquito carrying one of the four human malaria parasites, P. falciparum, P. vivax, P. malariae or P. ovale, according to statistics maintained by the World Health Organization. Falciparum infections are by far the most common, killing more than 1 million people each year. Malaria also contributes indirectly to many more deaths, mainly in young children, among those already suffering from other infections and illnesses. About 60 percent of the cases of malaria worldwide and more than 80 percent of malaria deaths occur in sub-Saharan Africa.

Boni, a mathematician as well as an evolutionary biologist, and his co-authors, Ramanan Laxminarayan and David Smith, designed a computer model with inputs based on more than 100 years of malaria field research. They simulated dozens of treatment paths for a malaria outbreak among patients contrasting many variations of the status quo strategy of using a single first-line therapy with one employing MFT.

They found there were major benefits to employing an MFT strategy, namely, fewer cases of malaria, fewer unsuccessful drug treatments, and a very significant delay in the onset of drug resistance in the parasites. As parasite resistance to antimalarial drugs is the key factor that can make drugs obsolete and useless, delaying and slowing down the evolution of drug-resistance is often viewed as a public health priority when designing strategies for eliminating or controlling malaria.

The computerized analysis conducted by the team represents the most extensive look yet at the question of what works best for large-scale and long-term malaria control. Boni, whose research focuses on the public health consequences of the evolution of infectious diseases, said their study was largely influenced by the work of the theoretical ecologist Simon Levin. Levin, the George M. Moffett Professor of Biology at Princeton, has over the past four decades pioneered techniques that apply rigorous mathematical analysis to biological problems, paving the way for work such as this, according to Boni.

Boni, who earned his bachelor's degree in mathematics from Princeton in 1999, has been a postdoctoral fellow in Levin's lab as well as in the Princeton Environmental Institute. Laxminarayan is both an economist at Resources for the Future in Washington, D.C., and a visiting research scholar at the Princeton Environmental Institute. Smith, who earned his doctoral degree in ecology and evolutionary biology from Princeton in 1998, is a mathematical epidemiologist and faculty member at the University of Florida.

The work was funded by the Bill and Melinda Gates Foundation and the National Institutes of Health.

Princeton University

---

---

	End Malaria by Michael Bungay Stanier (Editor) End Malaria is more than a book, it’s a great cause. At least $20 from each copy sold by us goes directly to Malaria No More to send a mosquito net to a family in need and to support life-saving work in the fight against malaria. Malaria No More, an international advocacy organization, is on a mission to end malaria related deaths by 2015. In addition to saving lives, buying this book means you can enjoy essays by 62 of American’s favorite business authors, including Tom Peters, Nicholas Carr, Pam Slim, and Sir Ken Robinson. Organized into three main sections—Focus, Courage, Resilience—and eight subsections—Tap Your Strengths, Create Freedom, Love & Be Kind, Disrupt Normal, Take Small Steps, Embrace Systems, Get Physical, Collaborate—all essays in End...
	The Making of a Tropical Disease: A Short History of Malaria (Johns Hopkins Biographies of Disease) by Randall M. Packard (Author) Malaria sickens hundreds of millions of people—and kills one to three million—each year. Despite massive efforts to eradicate the disease, it remains a major public health problem in poorer tropical regions. But malaria has not always been concentrated in tropical areas. How did other regions control malaria and why does the disease still flourish in some parts of the globe?From Russia to Bengal to Palm Beach, Randall Packard’s far-ranging narrative traces the natural and social forces that help malaria spread and make it deadly. He finds that war, land development, crumbling health systems, and globalization—coupled with climate change and changes in the distribution and flow of water—create conditions in which malaria's carrier mosquitoes thrive. The combination of these...
	The Fever: How Malaria Has Ruled Humankind for 500,000 Years by Sonia Shah (Author) In recent years, malaria has emerged as a cause célèbre for voguish philanthropists. Bill Gates, Bono, and Laura Bush are only a few of the personalities who have opened their pocketbooks in hopes of eradicating the scourge. How does a parasitic disease that we’ve known how to prevent for more than a century still infect three hundred million people every year, killing nearly one million of them? In The Fever, the journalist Sonia Shah sets out to answer this question, delivering a timely, inquisitive chronicle of the illness and its influence on human lives. The Fever captures the curiously fascinating, devastating history of this long-standing thorn in the side of humanity.
	The Imaginations of Unreasonable Men: Inspiration, Vision, and Purpose in the Quest to End Malaria by Bill Shore (Author) A small cadre of scientists—collaborators and competitors—are determined to develop a vaccine for malaria—a feat most tropical disease experts have long considered impossible. Skepticism, doubt, and a host of logistical and financial obstacles dog their quest. Success may ultimately elude them. Why, and how, do they persist? Bill Shore is a writer, philanthropist, and business leader who knows from personal experience the rare and elusive nature of transformative innovation. In this moving and inspiring book, the story of these uncompromising scientists serves as springboard for his passionate inquiry into the character and moral fabric of those who devote their lives to solving the world’s most pressing and perplexing problems. What does it take to achieve the impossible? It takes...
	The Malaria Capers : More Tales of Parasites and People, Research and Reality by Robert S. Desowitz (Author) "Reads like a murder mystery. . . . [Desowitz] writes with uncommon lucidity and verse, leaving the reader with a vivid understanding of malaria and other tropical diseases, and the ways in which culture, climate and politics have affected their spread and containment."—New York TimesWhy, Robert S. Desowitz asks, has biotechnical research on malaria produced so little when it had promised so much? An expert in tropical diseases, Desowtiz searches for answers in this provocative book.
	Little Things Make Big Differences: A Story about Malaria by John Nunes (Author)
	Quinine: Malaria and the Quest for a Cure That Changed the World by Fiammetta Rocco (Author) Quinine: The Jesuits discovered it. The Protestants feared it. The British vied with the Dutch for it, and the Nazis seized it. Because of quinine, medicine, warfare, and exploration were changed forever. For more than one thousand years, there was no cure for malaria. In 1623, after ten cardinals and hundreds of their attendants died in Rome while electing Urban VII the new pope, he announced that a cure must be found. He encouraged Jesuit priests establishing new missions in Asia and in South America to learn everything they could about how the local people treated the disease, and in 1631, an apothecarist in Peru named Agostino Salumbrino dispatched a new miracle to Rome. The cure was quinine, an alkaloid made from the bitter red bark of the cinchona tree. From the quest of the...
	Humanity's Burden: A Global History of Malaria (Studies in Environment and History) by James L.A. Webb Jr. (Author) Humanity's Burden provides a panoramic overview of the history of malaria. It traces the long arc of malaria out of tropical Africa into Eurasia, its transfer to the Americas during the early years of the Columbian exchange, and its retraction from the middle latitudes into the tropics since the late nineteenth century. Adopting a broadly comparative approach to historical patterns and processes, it synthesizes research findings from the natural and social sciences and weaves these understandings into a narrative that reaches from the earliest evidence of malaria infections in tropical Africa up to the present. Written in a style that is easily accessible to non-specialists, it considers the significance of genetic mutations, diet, lifestyle, migration, warfare, palliative and curative...
	Molecular Approaches to Malaria: by Irwin W. Sherman (Editor) "Molecular Approaches to Malaria" provides an overview of the rapid and significant developments that have occurred in malaria research, including the 2002 genome sequencing of Plasmodium falciparum and its mosquito vector, Anopheles gambiae. This work: provides a concise source of up-to-date research findings; appeals to a diverse audience, including malaria researchers, teachers, investigators, and public health professionals; offers contributions by recognized malaria researchers with practical experience; and, presents comprehensive coverage of topics including a clearly written introduction to Plasmodium molecular biology.
	Understanding Malaria: Fighting an Ancient Scourge Malaria is a disease caused by a parasite* that lives part of its life in humans and part in mosquitoes. Malaria remains one of the major killers of humans worldwide, threatening the lives of more than one-third of the world’s population. It thrives in the tropical areas of Asia, Africa, and Central and South America, where it strikes millions of people. Each year 350 to 500 million cases of malaria occur worldwide. Sadly, more than 1 million of its victims, mostly young children, die yearly. Although malaria has been virtually eradicated in the United States and other regions with temperate climates, it continues to affect hundreds of people in this country every year. The Centers for Disease Control and Prevention (CDC) estimates 1,200 cases of malaria are diagnosed each...